Clinical trial methodology.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 427, doi. 10.1002/pst.1534
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2012 AND VI 11 AND IP 5
Results: 13
1
2
Authors' reply to the letter to the editor on the paper 'Prediction of accrual closure date in multi-center clinical trials with discrete-time Poisson process models'.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 359, doi. 10.1002/pst.1527
- By:
- Publication type:
- Article
3
Discussion on the paper 'Prediction of accrual closure date in multi-center clinical trials with discrete-time Poisson process models', by Gong Tang, Yuan Kong, Chung-Chou Ho Chang, Lan Kong, and Joseph P. Costantino.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 357, doi. 10.1002/pst.1526
- By:
- Publication type:
- Article
4
Extreme value modelling of laboratory safety data from clinical studies.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 361, doi. 10.1002/pst.1510
- By:
- Publication type:
- Article
5
Discounting phase 2 results when planning phase 3 clinical trials.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 373, doi. 10.1002/pst.1521
- By:
- Publication type:
- Article
6
A proof-of-concept clinical trial design combined with dose-ranging exploration.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 403, doi. 10.1002/pst.1525
- By:
- Publication type:
- Article
7
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 417, doi. 10.1002/pst.1529
- By:
- Publication type:
- Article
8
Multivariate extreme value modelling of laboratory safety data from clinical studies.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 367, doi. 10.1002/pst.1531
- By:
- Publication type:
- Article
9
Attenuation of treatment effect due to measurement variability in assessment of progression-free survival.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 394, doi. 10.1002/pst.1524
- By:
- Publication type:
- Article
10
Literature Review April 2012-June 2012.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 425, doi. 10.1002/pst.1535
- By:
- Publication type:
- Article
11
Prediction of accrual closure date in multi-center clinical trials with discrete-time Poisson process models.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 351, doi. 10.1002/pst.1506
- By:
- Publication type:
- Article
12
The statistician's role in the prevention of missing data.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 410, doi. 10.1002/pst.1528
- By:
- Publication type:
- Article
13
Confidence intervals for the difference of marginal probabilities in clustered matched-pair binary data.
- Published in:
- Pharmaceutical Statistics, 2012, v. 11, n. 5, p. 386, doi. 10.1002/pst.1523
- By:
- Publication type:
- Article